Blog – Page 26 – Scilex Holding

Blog

11 Feb

Statement of acquisition of beneficial ownership by individuals

November 17, 2022
Posted by Jitendra

03 Feb

Statement of acquisition of beneficial ownership by individuals

November 17, 2022
Posted by Jitendra

02 Feb

Statement of acquisition of beneficial ownership by individuals – Amendment

November 17, 2022
Posted by Jitendra

10 Jan

Statement of acquisition of beneficial ownership by individuals

November 17, 2022
Posted by Jitendra

07 Jan

Current report

November 17, 2022
Posted by Jitendra

13 Dec

Corporate Presentation

April 4, 2024
Posted by Jitendra

13 Dec

Scilex Holding Company Releases Corporate Presentation

April 4, 2024
Posted by Jitendra

Certain data in this Presentation was obtained from various external sources, and neither Scilex nor its affiliates, advisers or representatives has verified such data with independent sources. Accordingly, neither Scilex nor any...

09 Dec

Scilex Holding Company, a Sorrento Therapeutics, Inc. Subsidiary, Announces Highly Significant Positive Top-Line Results from its Phase 3 Non-Opioid Injectable SP-102 (SEMDEXA™) Pivotal Trial C.L.E.A.R. Program for Sciatica Pain Management Supporting the

December 9, 2021
Posted by Jitendra

December 9, 2021 at 9:00 AM EST Scilex Holding Company, a commercial-stage, non-opioid biopharmaceutical pain management company, announces highly significant positive top-line results from its Phase 3 SP-102 (SEMDEXA™)...

08 Dec

Quarterly report for quarter ending Sept 30, 2021 – Amendment

November 17, 2022
Posted by Jitendra

07 Dec

Current report

November 17, 2022
Posted by Jitendra

«‹24 252627 28 ›»